Ceramidase Deficiency in Farber's Disease (Lipogranulomatosis)
- 8 December 1972
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 178 (4065) , 1100-1102
- https://doi.org/10.1126/science.178.4065.1100
Abstract
Ceramidase activity could not be demonstrated in the kidney and cerebellum from a deceased patient with Farber's disease, whereas the activities of six control acid hydrolase enzymes appeared normal. This enzyme defect presumably accounts for the accumulation that has been described in two patients and may represent the biochemical basis of this disorder.Keywords
This publication has 19 references indexed in Scilit:
- Ceramides in a Patient with Lipogranulomatosis (Farber's Disease) with Chronic CourseScandinavian Journal of Clinical and Laboratory Investigation, 1971
- CHEMICAL STUDIES OF FARBER'S DISEASEActa Neurologica Scandinavica, 1970
- A derangement in B12 metabolism associated with homocystinemia, cystathioninemia, hypomethioninemia and methylmalonic aciduriaThe American Journal of Medicine, 1970
- Farber's lipogranulomatosisThe American Journal of Medicine, 1969
- Demonstration of an alteration of ganglioside metabolism in Tay-Sachs diseaseBiochemical and Biophysical Research Communications, 1969
- Enzymic hydrolysis of sphingolipids. VIII. Purification and properties of rat brain ceramidaseBiochemistry, 1969
- Ceramide and Ganglioside Accumulation in Farber's Lipogranulomatosis.Experimental Biology and Medicine, 1967
- Enzymatic synthesis of ceramideBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1966
- A disorder of mucopolysaccharide metabolism with articular, respiratory, and neurologic manifestationsArthritis & Rheumatism, 1966
- Farber's disease: Report of a case with observations on its histogenesis and notes on the nature of the stored materialThe Journal of Pediatrics, 1962